[go: up one dir, main page]

AUPO203596A0 - Hormone therapy - Google Patents

Hormone therapy

Info

Publication number
AUPO203596A0
AUPO203596A0 AUPO2035A AUPO203596A AUPO203596A0 AU PO203596 A0 AUPO203596 A0 AU PO203596A0 AU PO2035 A AUPO2035 A AU PO2035A AU PO203596 A AUPO203596 A AU PO203596A AU PO203596 A0 AUPO203596 A0 AU PO203596A0
Authority
AU
Australia
Prior art keywords
hormone therapy
hormone
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPO2035A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceuticals Australia Pty Ltd
Original Assignee
Peptide Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peptide Technology Ltd filed Critical Peptide Technology Ltd
Priority to AUPO2035A priority Critical patent/AUPO203596A0/en
Publication of AUPO203596A0 publication Critical patent/AUPO203596A0/en
Priority to NZ334236A priority patent/NZ334236A/en
Priority to AT97936524T priority patent/ATE359805T1/en
Priority to CA2264562A priority patent/CA2264562C/en
Priority to CN971975485A priority patent/CN1216636C/en
Priority to DK97936524T priority patent/DK1007080T3/en
Priority to EP97936524A priority patent/EP1007080B1/en
Priority to JP51105398A priority patent/JP3860841B2/en
Priority to PCT/AU1997/000560 priority patent/WO1998008533A1/en
Priority to AU39345/97A priority patent/AU713413B2/en
Priority to ES97936524T priority patent/ES2285737T3/en
Priority to HK00101268.3A priority patent/HK1022275B/en
Priority to US09/242,635 priority patent/US6337318B1/en
Priority to DE69737635T priority patent/DE69737635T2/en
Priority to US09/991,714 priority patent/US6777386B2/en
Priority to US10/808,504 priority patent/US7309689B2/en
Abandoned legal-status Critical Current

Links

AUPO2035A 1996-08-30 1996-08-30 Hormone therapy Abandoned AUPO203596A0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
AUPO2035A AUPO203596A0 (en) 1996-08-30 1996-08-30 Hormone therapy
DE69737635T DE69737635T2 (en) 1996-08-30 1997-09-01 Delayed release formulation of peptide agonists and analogs of GnRH
EP97936524A EP1007080B1 (en) 1996-08-30 1997-09-01 Formulation for the sustained release of peptide agonists and analogues of GnRH
PCT/AU1997/000560 WO1998008533A1 (en) 1996-08-30 1997-09-01 Sustained peptide-release formulation
CA2264562A CA2264562C (en) 1996-08-30 1997-09-01 Sustained peptide-release formulation
CN971975485A CN1216636C (en) 1996-08-30 1997-09-01 Titanium slow-release composition
DK97936524T DK1007080T3 (en) 1996-08-30 1997-09-01 Formulation for sustained release of peptide agonists and analogues of GnRH
NZ334236A NZ334236A (en) 1996-08-30 1997-09-01 Composition comprising GnRH, lecithin and stearin
JP51105398A JP3860841B2 (en) 1996-08-30 1997-09-01 Sustained peptide release formulation
AT97936524T ATE359805T1 (en) 1996-08-30 1997-09-01 SUSTAINED RELEASE FORMULATION OF GNRH PEPTIDE AGONISTS AND ANALOGS
AU39345/97A AU713413B2 (en) 1996-08-30 1997-09-01 Sustained peptide-release formulation
ES97936524T ES2285737T3 (en) 1996-08-30 1997-09-01 PROLONGED RELEASE FORM OF GNRH AGEPISTS AND PEPTIDAL ANALOGS.
HK00101268.3A HK1022275B (en) 1996-08-30 1997-09-01 Sustained peptide-release formulation
US09/242,635 US6337318B1 (en) 1996-08-30 1997-09-01 Sustained GnRH peptide-release formulation
US09/991,714 US6777386B2 (en) 1996-08-30 2001-11-26 Sustained peptide-release formulation
US10/808,504 US7309689B2 (en) 1996-08-30 2004-03-25 Sustained peptide-release formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPO2035A AUPO203596A0 (en) 1996-08-30 1996-08-30 Hormone therapy

Publications (1)

Publication Number Publication Date
AUPO203596A0 true AUPO203596A0 (en) 1996-09-26

Family

ID=3796348

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPO2035A Abandoned AUPO203596A0 (en) 1996-08-30 1996-08-30 Hormone therapy

Country Status (1)

Country Link
AU (1) AUPO203596A0 (en)

Similar Documents

Publication Publication Date Title
AUPO203996A0 (en) Therapeutic uses
AU2263197A (en) Diabetes therapy
AU3043997A (en) Electrotherapy device
EP0796628A3 (en) Inhaler
AU4787697A (en) Therapeutic gene
AU3550197A (en) Syringes
AU3539297A (en) Transdermal therapeutic systems
AU3667297A (en) Therapy for combined hyperlipidemia
AUPO434196A0 (en) An improved therapeutic
AU2547895A (en) Therapeutic phenoxyalkylheterocycles
AU1171099A (en) Therapeutic agents
AU4582597A (en) Therapeutic proteins
AU2574197A (en) Dhea combination therapy
AU7641098A (en) Therapeutic composition
AU5330198A (en) Therapeutic compounds
AU4724897A (en) Stimulating device
AUPO203596A0 (en) Hormone therapy
ZA977005B (en) Therapeutic uses
AUPO314896A0 (en) Therapeutic agent
AU3978697A (en) Plasmin-depletion therapy
HK1009402B (en) Total hormone replacement therapy
AUPO181796A0 (en) Therapeutic uses
GB9615350D0 (en) Hormone replacement therapy
AU2003200183A1 (en) Cholestrol-lowering Therapy
AUPO651397A0 (en) Therapeutic thermal-pack